+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
From
From
Biologics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Biologics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 181 Pages
  • Global
From
From
Skeletal Dysplasia Market - Product Thumbnail Image

Skeletal Dysplasia Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors Market 2024-2028 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors Market 2024-2028

  • Report
  • October 2024
  • 136 Pages
  • Global
From
From
Cluster Headache Market - Global Forecast 2025-2032 - Product Thumbnail Image

Cluster Headache Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 188 Pages
  • Global
From
From
From
Autoimmune Drugs Market 2024-2028 - Product Thumbnail Image

Autoimmune Drugs Market 2024-2028

  • Report
  • July 2024
  • 185 Pages
  • Global
From
Pharmaceuticals Market in Germany 2024-2028 - Product Thumbnail Image

Pharmaceuticals Market in Germany 2024-2028

  • Report
  • August 2024
  • 130 Pages
  • Germany
From
From
Fibromyalgia Treatment Market Report 2025 - Product Thumbnail Image

Fibromyalgia Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Loading Indicator